Efficacy of Bevacizumab and Gemcitabine in Combination with Cisplatin in the Treatment of Esophageal Cancer and the Effect on the Incidence of Adverse Reactions

Table 3

The incidence of all grade CTCAE.

Groups		Grade I	Grade II	Grade III	Grade IV	Grade V	All grade
Control group	50	18	9	4	2	0	33
Study group	50	21	8	5	2	1	38
							1.214
							0.271